The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes.
about
Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: results from a multicentre prospective studyDietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of Swedish men.Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up.Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrationsSerum glucose and risk of cancer: a meta-analysis.New strategies in prostate cancer: targeting lipogenic pathways and the energy sensor AMPKMetabolic alterations and targeted therapies in prostate cancer.Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, CanadaMetabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) studyThe impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based studyPPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation.Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrenceHypertension and risk of prostate cancer: a systematic review and meta-analysisUrological aspects of the metabolic syndrome.Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis.The fat side of prostate cancer.Effects of Serum Triglycerides on Prostate Cancer and Breast Cancer Risk: A Meta-Analysis of Prospective Studies.A latent class model for competing risks.Transcriptome evaluation of the relation between body mass index and prostate cancer outcomes.Meta-analysis of metabolic syndrome and prostate cancer.Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.Association between metabolic syndrome, diabetes mellitus and prostate cancer risk.Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives.Midlife metabolic factors and prostate cancer risk in later life.Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis.Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies.Serum calcium and incident and fatal prostate cancer in the Swedish AMORIS study
P2860
Q28596648-2339CDF7-E0F8-400C-BAF6-D89C0C1FBC25Q34039257-DF384EDE-4C84-4C1E-90F8-4F6C62AF56C7Q34044105-DB26056D-FCB9-4F6E-B6B2-5685F0189C6BQ34465110-6ACE5DCA-5F4B-4490-9890-80F81F22D22FQ35059999-EF6CC743-53D8-4A8C-AF17-D006E6A5A9D8Q35222084-4E687D63-C24A-4FEA-9E3E-5F37B8CE30CBQ35401667-75C418BB-4D3F-4069-BDF0-D199B39AE992Q35781093-02BAD12A-E51A-48B0-BAF5-6B3DE4D8C8C2Q36044730-58F1993D-3F64-4D44-B324-59987A9F9E4FQ36117229-9BA24C87-D771-425E-B13E-37CA22BCE8D0Q36211459-582827FA-E3A8-4112-A5DB-8B4154C44C56Q36334568-6E6B5F91-7611-4794-833E-CCCC0B0090C0Q36688560-862DF337-B8E8-44F0-B324-0E00E66A02D5Q37166965-2B50FAE6-39FF-40CD-95BC-BC8E43BAA236Q37910709-45EE5908-BBA8-4E65-BD29-473C9A8E89DAQ38088550-C203008F-2BAA-4A70-B4B1-797BC58EEA50Q38096735-2782AF7F-7231-4EF7-8C1D-0BB53885A66CQ38377423-319A03C8-AACA-4CF5-B394-7D0D03D2B1B6Q38944623-C978DCEF-781B-414A-93BB-E1345B072EC0Q38989776-19FC6E33-BD0D-4C81-8427-B8779532CC4BQ39145052-F3C03B08-D718-4BFC-A204-06C834009C5BQ40376269-EC18D808-F853-4D9E-9EFF-BDCF47439F6BQ43686215-B84593A8-E7CD-4D2C-B4A6-B814176F5BAEQ46981314-D7B7ED02-96FB-4727-A8CB-ED1BA3800F88Q47129584-29F38662-6BA5-4B97-965B-4DFD2715FD75Q48346823-5800ED3F-D9A2-4893-B43A-BBFAB1894A21Q51252929-BB940819-A695-4C49-A71B-91B715021819Q53108925-43A5D521-B091-444C-BFB1-273A11A2607FQ58813375-4908DF62-3357-49AD-B02C-D32CAEC280DE
P2860
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The metabolic syndrome and the ...... ks of death from other causes.
@ast
The metabolic syndrome and the ...... ks of death from other causes.
@en
The metabolic syndrome and the ...... ks of death from other causes.
@nl
type
label
The metabolic syndrome and the ...... ks of death from other causes.
@ast
The metabolic syndrome and the ...... ks of death from other causes.
@en
The metabolic syndrome and the ...... ks of death from other causes.
@nl
prefLabel
The metabolic syndrome and the ...... ks of death from other causes.
@ast
The metabolic syndrome and the ...... ks of death from other causes.
@en
The metabolic syndrome and the ...... ks of death from other causes.
@nl
P2860
P50
P1476
The metabolic syndrome and the ...... ks of death from other causes.
@en
P2093
Birgitta Grundmark
Christer Busch
P2860
P304
P356
10.1158/1055-9965.EPI-10-0112
P577
2010-07-20T00:00:00Z